GTR 116786876
Tenders Are Invited For Recombinant Human Erythropoietin (Alfa Rh Epo) 2000 I.U Per Vial Or Pfs Solution For Injection Or Its Approved Biosimilar (Alfa Orzeta)
ICB — International Competitive Bid
Closes Aug 23, 2026
Asia
Tender Information
GTR Reference
116786876
Tendering Authority
Subscribe to view
Tender No
Med 10/2026/AA
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Recombinant Human Erythropoietin (Alfa Rh Epo) 2000 I.U Per Vial Or Pfs Solution For Injection Or Its Approved Biosimilar (Alfa Orzeta)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Arab World1,Middle East,Middle East and North Africa, MENA
Last Date of Bid Submission
23-08-2026
Work Detail
Tenders are invited for Recombinant Human Erythropoietin (Alfa rh EPO) 2000 I.U Per Vial or PFS Solution for Injection or its Approved Biosimilar (Alfa orZeta), Etc "Recombinant human erythropoietin (alfa rh EPO) 2000 I.U per vial or PFS solution for injection or its approved biosimilar (alfa orZeta)" Darbepoetin alfa 20 mcg (pre-filled syringe or injection device; SC/IV administration): The monthly treatment cost must not exceed the cost of erythropoietin under the most recent contract (Lowest Price Rule). Closing Date: 23/8/2026 Tender Link : https://kimadia.gov.iq/en/category/medicines/
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
b6e06345-5716-4216-963d-400ef277ab23.htm
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.